Partner Headlines - BMY

  1. Rayno 2016 Life Science Portfolio Update

    TalkMarkets
  2. The Gap Inc. Leads 85 Stocks Going Ex-Dividend Next Week

    Dividend.com
  3. Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to ...

    TalkMarkets
  4. Trending on Dividend.com: Bristol-Myers Disappoints and DHT Surprises, ...

    Dividend.com
  5. 3 Big Drugmakers That Beat Wall Street Q2 Estimates Thursday

    Investors Business Daily
  6. Amazon, Alphabet, Baidu, Ford, Celgene On Tap Thursday

    Investors Business Daily
  7. Investing Action Plan: Amazon, Alphabet, Baidu, Ford, Celgene

    Investors Business Daily
  8. Investing Action Plan: Apple, Facebook, Amazon, Big Oil, Boeing, ...

    Investors Business Daily
  9. 5 Big Drugmakers Reporting Earnings Next Week

    Investors Business Daily
  10. Ken Fisher's Best Investments: Credicorp, Ambev, Tata Motors

    GuruFocus
  11. Bristol-Myers Looks To A Promising Future

    Benzinga
  12. Barron's Picks And Pans: Bristol-Myers Squibb, KeyCorp, Core-Mark ...

    Benzinga
  13. Intercept Pharma Spikes On Report That It’s Exploring A Sale

    IBD
  14. Earnings Recap For January 28

    Benzinga
  15. Bristol Myers Ticks Higher Following Q4 Beat, Encouraging Guidance

    Benzinga
  16. 10 Fund Managers Are Totally Wrong on GlaxoSmithKline

    GuruFocus
  17. JNJ Kicks Off Health Care Earnings—What About Deals, Buybacks?

    Benzinga
  18. Stock Marquee Crowded With Oil, Apple, and the Fed

    Benzinga
  19. Benzinga's Top Downgrades

    Benzinga
  20. Bristol-Myers Squibb's Opdivo + Yervoy Receives Expanded FDA ...

    Benzinga
  21. Benzinga's Top Upgrades

    Benzinga
  22. Fast Money Traders Share Their Biotech Picks

    Benzinga
  23. Dual Therapeutics Announces Oncology Strategic Collaboration ...

    GuruFocus
  24. Mylan, Momenta Team Up To Develop Biosimilar Drugs

    IBD
  25. 3 Potential Blockbuster Drugs Launching in 2016

    IBD
  26. Lilly Guidance Misses Estimates On Lower Sales

    IBD
  27. Baxalta Cuts Cancer Deal As Shire Circles Nearer

    IBD
  28. 5 Top Stocks of the Outperforming Vanguard Health Care Fund

    GuruFocus
  29. Glaxo's ViiV Acquiring Bristol-Myers' HIV Candidates

    IBD
  30. Bristol-Myers Squibb to Sell its HIV R&D Portfolio to ViiV Healthcare ...

    Benzinga
  31. Strategic Beta ETFs Among Year's Top Performers

    IBD
  32. Fast Money Picks For December 15

    Benzinga
  33. Signature Select Sells Stake in SPDR Gold Trust

    GuruFocus
  34. Bristol-Myers Squibb CompanyNew Longer-Term Data for Empliciti ...

    Benzinga
  35. Amgen Expands Work With Merck, Files Biosimilar In EU

    IBD
  36. Bristol-Myers Squibb's

    IBD
  37. Bristol-Myers Plans Projects

    IBD
  38. Bristol-Myers Looks Beyond Cancer To Build Portfolio

    IBD
  39. Bristol-Myers Squibb Announces U.S. Food and Drug Administration ...

    Benzinga
  40. Goldman Sachs' Top 4 Smid-Cap Biotech Picks

    IBD
  41. Gilead Seen Staying Top Dog In HCV, But Merck Rising

    IBD
  42. BRISTOL-MYERS SQUIBB'S

    IBD
  43. Pamela Anderson And Hepatitis C: Which Drug Makers Are Working ...

    Benzinga
  44. Celgene Reports Mixed Q3 As Cancer Rivals Rise

    IBD
  45. Celgene Reports Mixed Q3 As Cancer Rivals Rise

    IBD
  46. How This Top Stock Mutual Fund Manager Seeks Growth

    IBD
  47. How This Top Stock Mutual Fund Manager Seeks Growth

    IBD
  48. Bristol-Myers Squibb

    IBD
  49. Gilead Outlook Disappoints

    IBD
  50. 4 Drugmakers Who Beat Q3 Estimates Tuesday

    IBD
  51. These Three Pharma Giants Just Crushed Earnings

    Benzinga
  52. Earnings Scheduled For October 27, 2015

    Benzinga
  53. Earnings Boom This Week: Big Pharma, E-Commerce Giant BABA And ...

    Benzinga
  54. Fed Meeting A Mid-Week Bump In Flurry Of Earnings News

    Benzinga
  55. Eli Lilly Q3 Earnings, Guidance Beat On Cost Control

    IBD
  56. Bristol-Myers Squibb Says NICE Recommends Daklinza for Treatment ...

    Benzinga
  57. Mid-Afternoon Market Update: Dow Jumps 175 Points; Garmin Shares ...

    Benzinga
  58. Mid-Day Market Update: Crude Oil Down 2%; Five Prime Therapeutics ...

    Benzinga
  59. Benzinga's Volume Movers

    Benzinga
  60. Mid-Morning Market Update: Markets Rise; Citigroup Profit Tops ...

    Benzinga
  61. Morning Market Gainers

    Benzinga
  62. Benzinga's Top #PreMarket Gainers

    Benzinga
  63. Bristol-Myers Squibb, Five Prime Therapeutics Announce Worldwide ...

    Benzinga
  64. Five Prime Therapeutics to Host Conference Call on Worldwide ...

    Benzinga
  65. Bristol-Myers drug approved

    IBD
  66. Bristol-Myers' Opdivo Gets Another Early Approval

    IBD
  67. Full SEC Comments Regarding Bristol-Myers Squibb FCPA Violations

    Benzinga
  68. Facebook, Netflix Top Goldman Sachs' 2016 Growth List

    IBD
  69. Alexion, Vertex Steal Mo Stanley's Eyes From Gilead

    IBD
  70. Fast Money Picks For October 2

    Benzinga
  71. Bristol-Myers Squibb Receives Approval from the U.S. Food and ...

    Benzinga
  72. 3 Big Drugs Likely To Hit The Market Soon

    IBD
  73. Bristol-Myers, J&J Upgraded On New Drug Prospects

    IBD
  74. Benzinga's Top Upgrades

    Benzinga
  75. Yahoo PT Cut Despite Alibaba; McDonald's Upgraded

    IBD
  76. Wall Street Ends Mixed After Seesaw Session

    FoxBusiness
  77. Opdivo (nivolumab) Demonstrates Long Term Survival Benefit in ...

    Benzinga
  78. Arrowhead Hits Target In Hepatitis B Drug Trial

    IBD
  79. Fast Money Picks For September 21

    Benzinga
  80. Make The World A Better Place With...Stock Picks?

    Benzinga
  81. Jim Cramer Shares His Thoughts On Home Depot, Bristol-Myers Squibb, ...

    Benzinga
  82. Amgen And Biogen Lead Short Interest Surge In Biotechs

    Benzinga
  83. Designing the Appropriate Common Stock Retirement Portfolio: ...

    GuruFocus
  84. Fast Money Picks For September 10

    Benzinga
  85. Mike Khouw Sees Unusual Options Activity In Bristol-Myers Squibb

    Benzinga
  86. BMY Announces CheckMate -017, -063 Trials Evaluating Opdivo in ...

    Benzinga
  87. BMY Announces Opdivo+Yervoy Dosing Schedules Showed Acceptable ...

    Benzinga
  88. Bristol-Myers Squibb to Host Investor Teleconference to Discuss ...

    Benzinga
  89. U.S. Food and Drug Administration Accepts for Priority Review ...

    Benzinga
  90. Benzinga's M&A Chatter for Thursday August 27, 2015

    Benzinga
  91. Allied-Bristol Life Sciences Licenses Platform Technology and ...

    Benzinga
  92. Weekly Insider Sells Highlight: IMS, NOW, BMY, EA

    GuruFocus
  93. uniQure Receives Additional $53M from Bristol-Myers Squibb for ...

    Benzinga
  94. Gilead Q2 Earnings Soar As HCV Shines, HIV Rebounds

    IBD
  95. Pfizer, Merck Beat Q2 Views; Sanofi Makes PD-1 Deal

    IBD
  96. Biogen's Big-Volume Plunge Marks End Of 5-Year Run

    IBD
  97. Valeant Posts Princely Gains

    IBD
  98. Bristol-Myers Q2 profit jumps

    IBD
  99. 3 Big-Cap Drugmakers Who Beat Q2 Earnings Estimates

    IBD
  100. Shire Lifts 2015 Guidance On Strong Drug Pipeline

    IBD
Trading Center